These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34272901)

  • 1. Head and neck osteosarcomas: Analysis of treatment trends and survival outcomes in the United States (2004-2016).
    Shim T; Chillakuru Y; Darwish C; Chalif E; Strum D; Benito DA; Mulcahy CF; Monfared A
    Head Neck; 2021 Nov; 43(11):3294-3305. PubMed ID: 34272901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in head and neck osteosarcoma: Adjuvant chemotherapy improves overall survival.
    Chen Y; Gokavarapu S; Shen Q; Liu F; Cao W; Ling Y; Ji T
    Oral Oncol; 2017 Oct; 73():124-131. PubMed ID: 28939064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cancer Data Base report on osteosarcoma of the head and neck.
    Smith RB; Apostolakis LW; Karnell LH; Koch BB; Robinson RA; Zhen W; Menck HR; Hoffman HT
    Cancer; 2003 Oct; 98(8):1670-80. PubMed ID: 14534884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma of head and neck: A retrospective study on prognostic factors from a single institute database.
    Chen Y; Shen Q; Gokavarapu S; Lin C; Yahiya ; Cao W; Chauhan S; Liu Z; Ji T; Tian Z
    Oral Oncol; 2016 Jul; 58():1-7. PubMed ID: 27311395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does neoadjuvant chemotherapy provide a survival benefit in maxillofacial osteosarcoma: A systematic review and pooled analysis.
    Khadembaschi D; Jafri M; Praveen P; Parmar S; Breik O
    Oral Oncol; 2022 Dec; 135():106133. PubMed ID: 36228524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?
    Bialick S; Campoverde L; Gallegos JAO; Barreto-Coelho P; Watson A; Arora K; Perez A; Lopez E; Venkat S; Rosenberg AE; Crawford B; Jonczak E; Trent J; Dhir A; D'Amato G
    Curr Treat Options Oncol; 2023 May; 24(5):528-541. PubMed ID: 37017908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma in patients over 50 years of age: Multi-institutional retrospective analysis of 104 patients.
    Nagano A; Matsumoto S; Kawai A; Okuma T; Hiraga H; Matsumoto Y; Nishida Y; Yonemoto T; Hosaka M; Takahashi M; Yoshikawa H; Kunisada T; Asanuma K; Naka N; Emori M; Kubo T; Kawashima H; Kawamoto T; Yokoyama R; Tsukushi S; Sato K; Okamoto T; Hiraoka K; Morioka H; Tanaka K; Takagi T; Iwamoto Y; Ozaki T
    J Orthop Sci; 2020 Mar; 25(2):319-323. PubMed ID: 31155441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional osteosarcoma of the mandible successfully treated with radical surgery and adjuvant chemotherapy after responding poorly to neoadjuvant chemotherapy: a case report.
    Kimura Y; Tomihara K; Tachinami H; Imaue S; Nakamori K; Fujiwara K; Suzuki K; Yasuda T; Miwa S; Nakayama E; Noguchi M
    J Med Case Rep; 2017 Aug; 11(1):210. PubMed ID: 28764797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers.
    Bouaoud J; Beinse G; Epaillard N; Amor-Sehlil M; Bidault F; Brocheriou I; Hervé G; Spano JP; Janot F; Boudou-Rouquette P; Benassarou M; Schouman T; Goudot P; Malouf G; Goldwasser F; Bertolus C
    Oral Oncol; 2019 Aug; 95():79-86. PubMed ID: 31345398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neoadjuvant treatment in the management of osteosarcomas of the head and neck.
    Mücke T; Mitchell DA; Tannapfel A; Wolff KD; Loeffelbein DJ; Kanatas A
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):127-31. PubMed ID: 24276589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 14. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiation therapy in resected high-grade localized skeletal osteosarcomas treated with neoadjuvant chemotherapy: Long-term outcomes.
    Sole CV; Calvo FA; Alvarez E; Cambeiro M; Cuervo M; San Julian M; Sole S; Martinez-Monge R; Sierrasesumaga L
    Radiother Oncol; 2016 Apr; 119(1):30-4. PubMed ID: 26970678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis.
    Cannon RB; Carpenter PS; Boothe D; Buchmann LO; Hunt JP; Lloyd S; Hitchcock YJ; Houlton JJ; Weis JR; Shepherd HM; Monroe MM
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):473-483. PubMed ID: 29661049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database.
    Byrne RM; Gilbert EW; Dewey EN; Herzig DO; Lu KC; Billingsley KG; Deveney KE; Tsikitis VL
    J Surg Res; 2019 Jun; 238():198-206. PubMed ID: 30772678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding osteosarcomas.
    Simpson E; Brown HL
    JAAPA; 2018 Aug; 31(8):15-19. PubMed ID: 29979330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.